TBPH Competitors & Alternatives
Compare Theravance Biopharma Inc with similar stocks in the same industry
Biotechnology
TBPH
Main Stock$17.01
Tradestie Score
50
Market Cap
$726.21M
P/E Ratio
16.3
Revenue Growth
-0.2%
Analyst Upside
+3.9%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$107.96
|
$900.91M | - | 34 | Compare |
|
GERN
Geron Corp
|
$1.52
|
$899.60M | - | 42 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$57.74
|
$894.30M | - | 48 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$23.88
|
$887.30M | - | 49 | Compare |
|
ANL
ANL
|
$13.70
|
$883.54M | - | 39 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$5.21
|
$879.90M | 6.0 | 39 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$8.87
|
$871.90M | - | 65 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$6.09
|
$867.49M | - | 43 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$18.39
|
$864.42M | - | 64 | Compare |
|
CRMD
CorMedix Inc.
|
$8.20
|
$862.55M | 3.9 | 37 | Compare |
More TBPH Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry